Showing results (201-210 of 241) with videos related to
Sort By:
Pageof 25
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.Protein Expression and Purification|December 10, 2015
Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domainA E Shannon, K J Chappell, M J Stoermer, et al.Annals of Surgery|June 24, 1998
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional reviewE L Bradley, P R Young, M C Chang, et al.Journal of Medical Virology|November 19, 2002
Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodiesV L Mathet, M Feld, L Espínola, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
IgG subclass-associated affinity differences of specific antibodies in humansM A Persson, S E Brown, M W Steward, et al.The Journal of Biological Chemistry|July 6, 2000
The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteinsS Uddin, F Lekmine, N Sharma, et al.Medical Hypotheses|May 1, 1988
The acid instability of myelin. A model for myelin degeneration in multiple sclerosisP R Young, W R Snyder, D A Vacante, et al.Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.The Journal of Biological Chemistry|October 3, 2001
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitorsD Leung, K Schroder, H White, et al.Pageof 25